Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	79.77	151.99	-84.54
Graham Fair Price	-44.76	18.54	33.57
PEG	64.01	0.09	0.05
Price/Book	-26.59	0.90	1.23
Price/Cash Flow	-51.25	-24.62	-16.28
Prices/Earnings	-120.09	-6.05	-2.75
Price/Sales	-38.78	1.73	2.82
Price/FCF	-51.25	-24.62	-16.28
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	54.92	0.23	0.15
Operating Margin	89.65	-0.01	-0.13
ROA	67.05	< 0.005	-0.02
ROE	-0.11	-0.04	66.64
ROIC	-0.02	< 0.005	87.45
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	3.14	-0.76	313.46
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.77	0.88	13.81
EPS QOQ	0.51	0.68	34.19
FCF QOQ	-2.77	0.53	-80.73
Revenue QOQ	-0.14	0.15	9.58
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	17.07	0.00	inf
Days Sales Outstanding (DSO)	20.57	15.81	-23.15
Inventory Turnover	5.27	0.00	inf
Debt/Capitalization	0.50	0.51	1.33
Quick Ratio	0.93	0.90	-3.21
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	21.16	20.24	-4.36
Cash	7.08	6.10	-13.92
Capex	-1.04	-0.27	73.73
Free Cash Flow	-1.60	-0.74	53.58
Revenue	9.22	10.58	14.70
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.11	1.04	-6.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-25.43	120.27	372.91
Naive Interpretation	Member

06 - Financial Health · Bad

Rating